BLUEBIRD BIO INC's ticker is and the CUSIP is 09609G900. A total of 4 filers reported holding BLUEBIRD BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $348,080 | -58.5% | 114,500 | -55.1% | 0.00% | – |
Q2 2023 | $838,621 | +859.0% | 254,900 | +826.9% | 0.00% | – |
Q1 2023 | $87,450 | -93.7% | 27,500 | -86.2% | 0.00% | -100.0% |
Q4 2022 | $1,379,156 | -47.2% | 199,300 | -51.7% | 0.00% | 0.0% |
Q3 2022 | $2,611,000 | +1040.2% | 412,500 | +647.3% | 0.00% | – |
Q2 2022 | $229,000 | – | 55,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 287,600 | $946,204 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 36,200 | $109 | 0.00% |
JANE STREET GROUP, LLC | 254,900 | $838,621 | 0.00% |
JPMORGAN CHASE & CO | 338,400 | $1,113,336 | 0.00% |